Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. Researchers administered weekly injections — either a placebo or ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

The race for oral GLP-1 weight loss drugs is intense. Pfizer drops a candidate, Eli Lilly shows progress, and Novo Nordisk seeks FDA approval for oral Wegovy.

New Superpower of Ozempic, Wegovy: Reversing Liver Disease. Story by Arden Dier • 1w. E xperts exploring what other conditions semaglutide, the active ingredient in Wegovy and Ozempic, ...

There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...

First, a drug like Ozempic mimics the natural GLP-1 hormone in your gut, which slows down digestion in the stomach and ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?